Novartis AG is 124.8x more valuable than Prestige Consumer Healthcare Inc. by market capitalization ($282.64 B vs $2.26 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | PBH | NVS |
|---|---|---|
| Market cap | $2.26 B | $282.64 B |
| US-listed rank | #2019 | #47 |
| Revenue (latest FY) | $1.09B | - |
| Net income (latest FY) | $190.30M | - |
| Net margin | 17.5% | - |
| P/E (trailing FY) | 11.9 | - |
| SEC filings | 1,235 | 947 |
Novartis AG is 124.8x more valuable than Prestige Consumer Healthcare Inc. by market capitalization ($282.64 B vs $2.26 B).
Full pages: Prestige Consumer Healthcare Inc. and Novartis AG, or browse the full rankings.